Furthermore, multiple other ligands, including transforming growth factor-α (TGF-α), can activate EGFR; thus, overexpression of such ligands could be implicated in ACC pathogenesis [145]. The gene discussed is EGFR; the disease is adrenal cortex carcinoma.